Com­pany name: Bio­An­a­lytix LLC.

Industry: Phar­ma­ceu­ti­cals.

Loca­tion: Boston, Massachusetts.

Solution/​product: Mass High Tech reported that the com­pany is a spinout of the Bar­nett Insti­tute of Chem­ical and Bio­log­ical Analysis at North­eastern Uni­ver­sity. The pub­li­ca­tion reported that CEO Kirt­land Poss said the insti­tute has been “ana­lyzing the makeup of large, com­plex mol­e­cules for biotechs” for years and decided to spin out the com­pany last year. Better char­ac­ter­i­za­tion of bio­logic and biosim­ilar drugs leads to more effi­cient drug devel­op­ment, he said.

Read the article at MedCity News →